𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer following irradiation in childhood and adolescence

✍ Scribed by Boice, John D.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
609 KB
Volume
27
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


This paper provides an overview of what is known concerning the oncogenic effects of radiation exposure during childhood and adolescence. The study populations include atomic bomb survivors, patients given radiotherapy to treat cancer or benign diseases, patients who received rather massive exposures during diagnostic radiographic procedures, persons exposed to environmental radiation, and children who received occupational exposures when working in underground mines (Table I).

ATOMIC BOMB SURVIVORS

Studies of survivors of the atomic bombs dropped on Hiroshima and Nagasaki in 1945 have provided valuable information on cancer risks following radiation exposure [ 11. The increase in recorded deaths due to either leukemia or solid tumors following exposures between 0.5 and 1 Gy are both statistically significant. The dose-response relationship for leukemia appears linear quadratic with a suggestion of a leveling off of risk at the highest doses. For radiation-induced solid tumors, the dose-response curve appears consistent with a straight line. There also is a suggestion at the highest doses that there might be a plateauing of effect, possibly related to the dominance of cell-killing over transformation at very high doses. A recent major publication on cancer incidence included articles clearly defining the oncogenic risks of radiation for many sites [2,3]. Cancer types with the highest relative risk coefficients include leukemia, breast, thyroid, and lung cancer. The particular mix of tumors following relatively low-dose whole-body exposures to the atomic bombs is different from that following therapeutic exposures in childhood, when sarcomas, brain tumors, and several other sites appear more often. It is also clear that children are at higher relative risk of radiation-induced cancers than adults (Table 11). For practically all sites the relative risk at 1 Gy is greater for those under the age of 20 at exposure than those over the age of 20. This age difference is particularly notable for leukemia, thyroid, breast, and skin cancer. Lung cancer is the only site for which the relative risk is elevated more among adults than children. On the other hand, the absolute excess risk


πŸ“œ SIMILAR VOLUMES


Thyroid and thymic malignancy following
✍ Dr. Mark O. Jensen; David Antonenko πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 272 KB

Synchronous thyroid and thymic malignancy following childhood thymic irradiation has only been reported in two known cases previously, with a third case identified here. A rationale is presented for following these radiated patients as they age with thyroglobulin and thyroid-stimulating hormone (TSH

Nasopharyngeal carcinoma in childhood an
✍ Serin, Meltem; Erkal, Haldun SΓΌkrΓΌ; Halil Elhan, Atilla; Γ‡akmak, Ahmet πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

Background. This study reviews the authors' experience from 1979 through 1996 in the management and outcome of 56 patients with nasopharyngeal carcinoma who were under 20 years of age. Procedure. There were 33 males and 23 females, their ages ranging from 7 to 19 years (median: 16 years). Forty pati

Treatment compliance in childhood and ad
✍ Cameron K. Tebbi πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 989 KB

Experience reveals that there is significant noncompliance with self-administered medication, especially in chronic conditions such as cancer. Noncompliance transcends the boundary of disease categories and age group. However, this is most prevalent during the adolescent years when the process of tr

Death during adulthood in survivors of c
✍ H. Stacy Nicholson; Thomas R. Fears; Julianne Byrne πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 772 KB

Background. Therapeutic advances have extended survival for most children and adolescents with cancer beyond 5 years from diagnosis. However, excess mortality continues beyond 5 years, and a significant portion results from causes other than the primary cancer. Risk factors for these deaths are not